Momate Nasal Spray Use In Pregnancy & Lactation

Use in Pregnancy: Pregnancy Teratogenic Effects: There are no adequate and well-controlled studies in pregnant women. Mometasone furoate monohydrate Nasal Spray 50 mcg like other corticosteroids, should be used during pregnancy only if the potential benefits justify the potential risk to the fetus. Experience with oral corticosteroids since their introduction in pharmacologic, as opposed to physiologic, doses suggests that rodents are more prone to teratogenic effects from corticosteroids than humans. In addition, because there is a natural increase in corticosteroid production during pregnancy, most women will require a lower exogenous corticosteroid dose and many do not need corticosteroid treatment during pregnancy.
Nonteratogenic Effects: Hypoadrenalism may occur in infants born to women receiving corticosteroids during pregnancy. Such infants should be carefully monitored.
Use in Lactation: It is not known if mometasone furoate is excreted in human milk. Because other corticosteroids are excreted in human milk, caution should be used when Mometasone furoate monohydrate Nasal Spray, 50 mcg is administered to nursing women.